๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A once daily theophylline preparation in prevention of nocturnal symptoms in childhood asthma

โœ Scribed by B. Bose; J. I. Cater; R. A. Clark


Publisher
Springer
Year
1987
Tongue
English
Weight
327 KB
Volume
146
Category
Article
ISSN
0340-6997

No coin nor oath required. For personal study only.

โœฆ Synopsis


Twenty school children with chronic asthma who despite regular prophylactic therapy continued to have troublesome nocturnal wheeze or cough entered a double-blind crossover study in which a once daily theophylline preparation was compared with placebo to assess control of these symptoms. Seventeen children completed both phases of the study. Significant improvement was noted in the day and night symptom scores, the morning dip index and daily peak flow readings with a significant reduction in rescue bronchodilator inhaler usage during the active treatment period. Satisfactory serum theophylline concentrations were obtained 11-12 h post dose in all children using a standard dose of 18 mg/kg per day at 2000 hours. Three children were withdrawn because of minor side-effects. The theophylline preparation studied in conjunction with other conventional anti-asthma therapy was thus effective in controlling nocturnal symptoms.


๐Ÿ“œ SIMILAR VOLUMES


Theophylline in acute childhood asthma:
โœ David C. Goodman; Benjamin Littenberg; Gerald T. O'Connor; John G. Brooks ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 690 KB

Although theophylline is a widely used drug for the treatment of acute childhood asthma, its efficacy has not been clearly established. This study constitutes a meta-analysis of published randomized clinical trials of theophylline in children hospitalized with acute asthma. We conducted a search of

Comparison of the efficacy, tolerability
โœ S. D. Gunn; J. G. Ayres; R. M. A. Follows; S. M. McConchie ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› Springer ๐ŸŒ English โš– 549 KB

The aim of the study was to compare the efficacy, tolerability and patient acceptability of bambuterol (Bambec ยฎ) against controlled release (CR) salbutamol (Volmax ยฎ) in the treatment of nocturnal asthma. One hundred and fifty two asthmatic patients aged 17-78 years, using \_> 800 ~tg/day of an in